サンプル依頼リスト カート
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：米国の体外診断薬市場：Medtech 360
市場調査レポート
商品コード
1508860

米国の体外診断薬市場：Medtech 360

In Vitro Diagnostics | Medtech 360 | Market Insights | United States

出版日
発行
Clarivate
ページ情報
英文
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
米国の体外診断薬市場：Medtech 360
出版日: 2024年06月27日
発行: Clarivate
ページ情報: 英文
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

米国の体外診断薬 (IVD) 市場は2033年まで緩やかな成長が見込まれます。慢性疾患や感染症の増加、高齢化の進展、「価値観に基づく医療」へのシフトが、診断精度の向上と所要時間の短縮を実現する新規検査や自動化IVDシステムの普及を後押しします。

IVD市場は多様で、複数の市場セグメントがあります。

  • どの検査市場が停滞しているのか？
  • 技術革新の余地があるのは、どの検査市場か？
  • デジタルヘルス技術は、これらのセグメントにどのように組み込まれるのか？

検査市場はどのように成長すると予想されますか？

  • 予測期間を通じて、最も高い成長を遂げる検査はどれか？
  • 新しい検査の採用は、IVD市場にどのような影響を与えますか？

IVDの競合情勢はダイナミックです。

  • この分野における多国籍企業と中小企業との戦略の違いは？
  • 検査施設がIVDメーカーを買収対象に選んだ際に考慮すべき主な購買基準とは？
  • 固定化が進んだ市場で、各企業はどのように差別化するのか？

当レポートでは、米国の体外診断薬 (IVD) の市場について分析し、全体的な市場動向の見通し (2019年～2033年) や、製品カテゴリー別の詳細動向、市場競争の状況 (主要企業の市場シェアほか)、主な市場促進・抑制要因、技術革新の影響などを調査しております。

目次

米国

概要

エグゼクティブサマリー

主要レポートの更新履歴

体外診断薬 (IVD) 市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合の考察
    • Roche
    • Abbott Laboratories
    • その他の主要な競合企業
    • すべての競合企業に影響を与える要因

臨床化学検査市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
    • 一般化学テスト
    • 糖尿病検査
    • 治療薬物モニタリング検査
    • 薬物乱用検査
    • 特定のタンパク質検査
    • 心臓マーカー
    • 血液ガス
  • 市場シェア
  • 競合の考察
    • 米国の臨床化学検査の競合考察
    • すべての競合企業に影響を与える要因

免疫測定検査市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
    • アレルギー検査
    • 貧血検査
    • 骨代謝検査
    • 心臓マーカー検査
    • 不妊症/ホルモン検査
    • 感染症検査
    • 特定のタンパク質
    • 甲状腺検査
    • 腫瘍マーカー検査
  • 市場シェア
  • 競合の考察
    • 米国の免疫測定検査の競合考察
    • すべての競合企業に影響を与える要因

微生物検査市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
    • 病理培養検査
    • 血液培養検査
    • 同定/抗生物質感受性試験
  • 市場シェア
  • 競合の考察
    • 米国の微生物学試験の競合考察

血液検査・凝固検査市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
    • 一般的なスクリーニングと抗凝固モニタリング検査
    • プロトロンビン時間検査
    • Dダイマー検査
    • フィブリン形成および分解試験
  • 市場シェア
  • 競合の考察
    • 米国の血液検査・凝固検査の競合考察

分子診断検査市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
    • 感染症検査
  • 市場シェア
  • 競合の考察
    • 米国の分子診断検査の競合考察

付録

目次
Product Code: 47042098

The US IVD market is expected to grow moderately through 2033, driven by the increasing prevalence of chronic and infectious diseases, the expanding aging population, and the shift toward value-based healthcare, which will fuel the uptake of novel tests and automated IVD systems that can offer improved diagnostic accuracy and reduced turnaround time.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2033.

The IVD market is diverse, with multiple market segments.

  • Which test markets are stagnant?
  • Which test markets are open to innovation?
  • How will digital health technology be integrated into these segments?

How are the test markets expected to grow?

  • Which tests will experience the highest growth throughout the forecast period?
  • How will the adoption of newer tests affect the IVD market?

The IVD competitive landscape is dynamic.

  • How do strategies differ between MNCs and smaller companies in this space?
  • What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?
  • How do competitors differentiate themselves in an entrenched market?

Table of Contents

United States

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Procedures Covered
  • Products Covered

Key Report Updates

In Vitro Diagnostics Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • Roche
    • Abbott Laboratories
    • Other Key Competitors
    • Factors Affecting All Competitors
  • Market Developments

Clinical Chemistry Test Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
    • General Chemistry Tests
    • Diabetes Tests
    • Therapeutic Drug Monitoring Tests
    • Drug of Abuse Testing
    • Specific Protein Tests
    • Cardiac Marker
    • Blood Gas
  • Market Shares
  • Competitive Insights
    • US Clinical Chemistry Test Competitive Insights
    • Factors Affecting All Competitors

Immunoassay Test Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
    • Allergy Tests
    • Anemia Tests
    • Bone Metabolism Tests
    • Cardiac Marker Tests
    • Fertility/Hormone Tests
    • Infectious Disease Tests
    • Specific Protein
    • Thyroid Tests
    • Tumor Marker Tests
  • Market Shares
  • Competitive Insights
    • US Immunoassay Test Competitive Insights
    • Factors Affecting All Competitors

Microbiology Test Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
    • Pathological Culture Tests
    • Blood Culture Tests
    • Identification/Antibiotic Susceptibility Testing
  • Market Shares
  • Competitive Insights
    • US Microbiology Test Competitive Insights

Hematology and Coagulation Test Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
    • General Screening and Anticoagulation Monitoring Tests
    • Prothrombin Time Tests
    • D-Dimer Tests
    • Fibrin Formation and Degradation Tests
  • Market Shares
  • Competitive Insights
    • US Hematology and Coagulation Test Competitive Insights

Molecular Diagnostic Test Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
    • Infectious Disease Tests
  • Market Shares
  • Competitive Insights
    • US Molecular Diagnostic Test Competitive Insights

Appendix

  • Abbreviations
  • Bibliography

Tables and Figures

  • IVD Market, by Application, US (USD), 2019-2033
  • IVD Market Landscape, US (USD), 2023 and 2033
  • IVD Test Revenue Market Share Rankings, by Application, US, 2023
  • Competitive Insights
  • Companies Mentioned
  • Recent Events in the IVD Market, US
  • IVD Procedures Covered, US
  • IVD Products1 Covered, US
  • US In Vitro Diagnostics Market Drivers
  • US In Vitro Diagnostics Market Limiters
  • IVD Market, by Application, US (USD), 2019-2033
  • IVD Market, by Product Type, US (USD), 2019-2033
  • IVD Market, by Setting, US (USD), 2019-2033
  • IVD Market, by Application, US (USD), 2019-2033
  • IVD Test Market, by Application, US (USD), 2019-2033
  • IVD Instrumentation Market, by Application, US (USD), 2019-2033
  • IVD Test Revenue Market Shares, US, 2023
  • IVD Test Revenue Market Shares, by Application, US, 2023
  • Roche Competitive Insights
  • Abbott Laboratories Competitive Insights
  • Competitive Insights for Other Key Competitors
  • Recent Events in the IVD Market, US
  • US Clinical Chemistry Test Market Drivers
  • US Clinical Chemistry Test Market Limiters
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2033
  • Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2033
  • Clinical Chemistry Test Market, by Setting, US (USD), 2019-2033
  • Clinical Chemistry Test Market, by Test Type, US (USD), 2019-2033
  • Alanine Aminotransferase Tests, by Setting, US, 2019-2033
  • Alkaline Phosphatase Tests, by Setting, US, 2019-2033
  • Aspartate Aminotransferase Tests, by Setting, US, 2019-2033
  • Bilirubin Tests, by Setting, US, 2019-2033
  • Calcium Tests, by Setting, US, 2019-2033
  • Comprehensive Metabolic Panel Tests, by Setting, US, 2019-2033
  • Creatinine Tests, by Setting, US, 2019-2033
  • Electrolyte Panel Tests, by Setting, US, 2019-2033
  • Hepatic Panel Tests, by Setting, US, 2019-2033
  • Human Chorionic Gonadotropin Tests, by Setting, US, 2019-2033
  • Lactate Tests, by Setting, US, 2019-2033
  • Lactate Dehydrogenase Tests, by Setting, US, 2019-2033
  • Lipase Tests, by Setting, US, 2019-2033
  • Lipid Panel Tests, by Setting, US, 2019-2033
  • Magnesium Tests, by Setting, US, 2019-2033
  • Metabolic Panel including Total Calcium Tests, by Setting, US, 2019-2033
  • Phosphorus Tests, by Setting, US, 2019-2033
  • Potassium Tests, by Setting, US, 2019-2033
  • Total Protein Tests, by Setting, US, 2019-2033
  • Uric Acid Tests, by Setting, US, 2019-2033
  • Other General Chemistry Tests, by Setting, US, 2019-2033
  • Blood Glucose (Non-Reagent-Strip) Tests, by Setting, US, 2019-2033
  • Blood Glucose Reagent Strip Tests, by Setting, US, 2019-2033
  • Glucose Tolerance Tests, by Setting, US, 2019-2033
  • HbA1c Tests, by Setting, US, 2019-2033
  • Insulin Tests, by Setting, US, 2019-2033
  • Microalbumin Quantitative Tests, by Setting, US, 2019-2033
  • Urine Glucose Tests, by Setting, US, 2019-2033
  • Other Diabetes Tests, by Setting, US, 2019-2033
  • Carbamazepine Tests, by Setting, US, 2019-2033
  • Cyclosporine Tests, by Setting, US, 2019-2033
  • Digoxin Tests, by Setting, US, 2019-2033
  • Phenobarbital Tests, by Setting, US, 2019-2033
  • Phenytoin (Total) Tests, by Setting, US, 2019-2033
  • Tacrolimus Tests, by Setting, US, 2019-2033
  • Theophylline Tests, by Setting, US, 2019-2033
  • Valproic Acid (Total) Tests, by Setting, US, 2019-2033
  • Vancomycin Tests, by Setting, US, 2019-2033
  • Other TDM Tests, by Setting, US, 2019-2033
  • Ethanol Tests, by Setting, US, 2019-2033
  • Acetaminophen Tests, by Setting, US, 2019-2033
  • Salicylate Tests, by Setting, US, 2019-2033
  • Antinuclear Antibody Tests, by Setting, US, 2019-2033
  • Haptoglobin Tests, by Setting, US, 2019-2033
  • Homocysteine Tests, by Setting, US, 2019-2033
  • Prealbumin Tests, by Setting, US, 2019-2033
  • Rheumatoid Factor Tests, by Setting, US, 2019-2033
  • Somatomedin Tests, by Setting, US, 2019-2033
  • Other Specific Protein Tests, by Setting, US, 2019-2033
  • Apolipoprotein Tests, by Setting, US, 2019-2033
  • Cholesterol Tests, by Setting, US, 2019-2033
  • C-Reactive Protein Tests, by Setting, US, 2019-2033
  • High Sensitivity C-Reactive Protein Tests, by Setting, US, 2019-2033
  • Low Density Lipoprotein Tests, by Setting, US, 2019-2033
  • Triglyceride Tests, by Setting, US, 2019-2033
  • Other Cardiac Marker Tests, by Setting, US, 2019-2033
  • Arterial Blood Gas Tests, by Setting, US, 2019-2033
  • Chloride Tests, by Setting, US, 2019-2033
  • Urea Nitrogen Tests, by Setting, US, 2019-2033
  • Other Blood Gas Tests, by Setting, US, 2019-2033
  • Clinical Chemistry Test Revenue Market Shares, US, 2023
  • Clinical Chemistry Test Revenue Market Shares, by Product Type, US, 2023
  • US Immunoassay Test Market Drivers
  • US Immunoassay Test Market Limiters
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2033
  • Immunoassay Test Market, by Product Type, US (USD), 2019-2033
  • Immunoassay Test Market, by Setting, US (USD), 2019-2033
  • Immunoassay Test Market, by Test Type, US (USD), 2019-2033
  • Allergy IgA, IgD, IgG, IgM Tests, by Setting, US, 2019-2033
  • Allergy IgE Tests, by Setting, US, 2019-2033
  • Immunoglobulin Subclasses Tests, by Setting, US, 2019-2033
  • Erythropoietin Tests, by Setting, US, 2019-2033
  • Ferritin Tests, by Setting, US, 2019-2033
  • Intrinsic Factor Antibody Tests, by Setting, US, 2019-2033
  • Iron Tests, by Setting, US, 2019-2033
  • Iron Binding Capacity Tests, by Setting, US, 2019-2033
  • Vitamin B-12 Tests, by Setting, US, 2019-2033
  • HGH Tests, by Setting, US, 2019-2033
  • Parathormone Tests, by Setting, US, 2019-2033
  • Vitamin D 25 Hydroxy Tests, by Setting, US, 2019-2033
  • Creatine Kinase Tests, by Setting, US, 2019-2033
  • CK-MB Tests, by Setting, US, 2019-2033
  • BNP Tests, by Setting, US, 2019-2033
  • Troponin Tests, by Setting, US, 2019-2033
  • ACTH Tests, by Setting, US, 2019-2033
  • Estradiol Tests, by Setting, US, 2019-2033
  • FSH Tests, by Setting, US, 2019-2033
  • LH Tests, by Setting, US, 2019-2033
  • Progesterone Tests, by Setting, US, 2019-2033
  • Prolactin Tests, by Setting, US, 2019-2033
  • Testosterone Tests, by Setting, US, 2019-2033
  • Other Fertility/Hormone Tests, by Setting, US, 2019-2033
  • Acute Hepatitis Tests, by Setting, US, 2019-2033
  • CMV Tests, by Setting, US, 2019-2033
  • Epstein-Barr Virus Tests, by Setting, US, 2019-2033
  • Hepatitis A Tests, by Setting, US, 2019-2033
  • Hepatitis B Tests, by Setting, US, 2019-2033
  • Hepatitis C Tests, by Setting, US, 2019-2033
  • HIV-1/HIV-2 Tests, by Setting, US, 2019-2033
  • HSV Tests, by Setting, US, 2019-2033
  • HSV Type 2 Tests, by Setting, US, 2019-2033
  • HTLV or HIV Tests, by Setting, US, 2019-2033
  • Influenza A/B Tests, by Setting, US, 2019-2033
  • Lyme Disease Tests, by Setting, US, 2019-2033
  • Microsomal Antibodies Tests, by Setting, US, 2019-2033
  • Nephelometry Tests, by Setting, US, 2019-2033
  • Parvovirus Tests, by Setting, US, 2019-2033
  • Respiratory Syncytial Virus Tests, by Setting, US, 2019-2033
  • Rotavirus Tests, by Setting, US, 2019-2033
  • Rubella Tests, by Setting, US, 2019-2033
  • Treponema Pallidum Tests, by Setting, US, 2019-2033
  • Varicella-Zoster Virus Tests, by Setting, US, 2019-2033
  • Other Infectious Disease Tests, by Setting, US, 2019-2033
  • Albumin Tests, by Setting, US, 2019-2033
  • Alpha-1 Antitrypsin Tests, by Setting, US, 2019-2033
  • Gamma-Glutamyl Transferase Tests, by Setting, US, 2019-2033
  • Thyroxine (Free) Tests, by Setting, US, 2019-2033
  • Thyroglobulin Tests, by Setting, US, 2019-2033
  • Thyroid (T3) Tests, by Setting, US, 2019-2033
  • Thyroid (T3 or T4) Tests, by Setting, US, 2019-2033
  • Thyroxine (Total) Tests, by Setting, US, 2019-2033
  • TSH Tests, by Setting, US, 2019-2033
  • Alpha-Fetoprotein Serum Tests, by Setting, US, 2019-2033
  • Beta-2 Microglobulin Tests, by Setting, US, 2019-2033
  • CA 125 Tests, by Setting, US, 2019-2033
  • CA 15-3 Tests, by Setting, US, 2019-2033
  • CA 19-9 Tests, by Setting, US, 2019-2033
  • Carcinoembryonic Antigen Tests, by Setting, US, 2019-2033
  • PSA (Free) Tests, by Setting, US, 2019-2033
  • PSA (Total) Tests, by Setting, US, 2019-2033
  • Other Tumor Marker Tests, by Setting, US, 2019-2033
  • Immunoassay Test Revenue Market Shares, US, 2023
  • Immunoassay Test Revenue Market Shares, by Product Type, US, 2023
  • US Microbiology Test Market Drivers
  • US Microbiology Test Market Limiters
  • Microbiology Test Market, by Product Type, US (USD), 2019-2033
  • Microbiology Test Market, by Product Type, US (USD), 2019-2033
  • Microbiology Test Market, by Setting, US (USD), 2019-2033
  • Microbiology Test Market, by Test Type, US (USD), 2019-2033
  • Salmonella and Shigella (Stool Culture) Tests, by Setting, US, 2019-2033
  • Other Pathogen (Stool Culture) Tests, by Setting, US, 2019-2033
  • Mycobacteria Culture Tests, by Setting, US, 2019-2033
  • Aerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2033
  • Anaerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2033
  • Urine Bacteria Culture Tests, by Setting, US, 2019-2033
  • Blood Culture Tests, by Setting, US, 2019-2033
  • Aerobic Culture Identification Tests, by Setting, US, 2019-2033
  • Anaerobic Culture Identification Tests, by Setting, US, 2019-2033
  • Immunologic Culture Identification Tests, by Setting, US, 2019-2033
  • MIC Tests, by Setting, US, 2019-2033
  • Microbe Susceptible Disk Tests, by Setting, US, 2019-2033
  • Presumptive Pathogenic Organisms Culture Tests, by Setting, US, 2019-2033
  • Yeast Identification Tests, by Setting, US, 2019-2033
  • Other ID/AST Tests, by Setting, US, 2019-2033
  • Microbiology Test Revenue Market Shares, US, 2023
  • Microbiology Test Revenue Market Shares, US, 2023
  • US Hematology and Coagulation Test Market Drivers
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2033
  • Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2033
  • Hematology and Coagulation Test Market, by Setting, US (USD), 2019-2033
  • Hematology and Coagulation Test Market, by Test Type, US (USD), 2019-2033
  • Automated Platelet Count Tests, by Setting, US, 2019-2033
  • Blood Smear with Differential White Blood Cell Count Tests, by Setting, US, 2019-2033
  • Complete CBC Automated Tests, by Setting, US, 2019-2033
  • Complete CBC with Automated White Blood Cell Count Tests, by Setting, US, 2019-2033
  • Erythrocyte Sedimentation Rate Tests, by Setting, US, 2019-2033
  • Hematocrit Tests, by Setting, US, 2019-2033
  • Hemoglobin Tests, by Setting, US, 2019-2033
  • Leukocyte Tests, by Setting, US, 2019-2033
  • Red Blood Cell Count Tests, by Setting, US, 2019-2033
  • Reticulocyte Tests, by Setting, US, 2019-2033
  • Sickle Cell Screen Tests, by Setting, US, 2019-2033
  • Transferrin Tests, by Setting, US, 2019-2033
  • Other General Screening and Anticoagulation Monitoring Tests, by Setting, US, 2019-2033
  • Prothrombin Time Tests, by Setting, US, 2019-2033
  • D-Dimer Tests, by Setting, US, 2019-2033
  • aPTT Tests, by Setting, US, 2019-2033
  • Fibrinogen Tests, by Setting, US, 2019-2033
  • Hematology and Coagulation Test Revenue Market Shares, US, 2023
  • Hematology and Coagulation Test Revenue Market Shares, by Product Type, US, 2023
  • US Molecular Diagnostic Test Market Drivers
  • US Molecular Diagnostic Test Market Limiters
  • MDx Test Market, by Product Type, US (USD), 2019-2033
  • MDx Test Market, by Product Type, US (USD), 2019-2033
  • MDx Test Market, by Setting, US (USD), 2019-2033
  • Chlamydia Tests, by Setting, US, 2019-2033
  • Clostridium Difficile Tests, by Setting, US, 2019-2033
  • Gonorrhea Tests, by Setting, US, 2019-2033
  • Hepatitis C Tests, by Setting, US, 2019-2033
  • HIV-1 Tests, by Setting, US, 2019-2033
  • HPV Tests, by Setting, US, 2019-2033
  • HSV Tests, by Setting, US, 2019-2033
  • Staphylococcus Aureus Tests, by Setting, US, 2019-2033
  • Streptococcus Group A Tests, by Setting, US, 2019-2033
  • Unspecified Infectious Agent Tests, by Setting, US, 2019-2033
  • Other Infectious Disease Tests, by Setting, US, 2019-2033
  • MDx Test Revenue Market Shares, US, 2023
  • MDx Test Revenue Market Shares, by Product Type, US, 2023